{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.6","upperLimit":"99.9","value":"99.8"},{"groupId":"OG001","lowerLimit":"99.7","upperLimit":"99.9","value":"99.8"}]}],"title":"Anti-HPV Type 6 (n=3993, 3975)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.9","upperLimit":"100","value":"100"},{"groupId":"OG001","lowerLimit":"99.8","upperLimit":"100","value":"99.9"}]}],"title":"Anti-HPV Type 11 (n=3995, 3982)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.9","upperLimit":"100","value":"100"},{"groupId":"OG001","lowerLimit":"99.8","upperLimit":"100","value":"100"}]}],"title":"Anti-HPV Type 16 (n=4032, 4062)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.7","upperLimit":"99.9","value":"99.8"},{"groupId":"OG001","lowerLimit":"99.5","upperLimit":"99.8","value":"99.7"}]}],"title":"Anti-HPV Type 18 (n=4539, 4541)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.6","upperLimit":"99.9","value":"99.8"},{"groupId":"OG001","lowerLimit":"48.7","upperLimit":"51.6","value":"50.1"}]}],"title":"Anti-HPV Type 31 (n=4466, 4377)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.5","upperLimit":"99.9","value":"99.7"},{"groupId":"OG001","lowerLimit":"11.8","upperLimit":"13.7","value":"12.7"}]}],"title":"Anti-HPV Type 33 (n=4702, 4691)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.4","upperLimit":"99.8","value":"99.6"},{"groupId":"OG001","lowerLimit":"8.4","upperLimit":"10.0","value":"9.2"}]}],"title":"Anti-HPV Type 45 (n=4792, 4750)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.6","upperLimit":"99.9","value":"99.8"},{"groupId":"OG001","lowerLimit":"2.2","upperLimit":"3.1","value":"2.6"}]}],"title":"Anti-HPV Type 52 (n=4455, 4335)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"99.6","upperLimit":"99.9","value":"99.8"},{"groupId":"OG001","lowerLimit":"19.2","upperLimit":"21.6","value":"20.4"}]}],"title":"Anti-HPV Type 58 (n=4486, 4446)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"6792"},{"groupId":"OG001","value":"6795"}],"units":"Participants"}],"description":"Serum antibodies to HPV types were measured with a Competitive Luminex Immunoassay. The serostatus cutoffs (milli Merck U/mL) for HPV types were as follows: HPV Type 6: ≥30; HPV Type 11: ≥16; HPV Type 16: ≥20; HPV Type 18: ≥24; HPV Type 31: ≥10; HPV Types 33, 45, 52, and 58: ≥8.","dispersionType":"95% Confidence Interval","groups":[{"description":"V503 (9-Valent HPV Vaccine) mid-dose 0.5 mL injection in a 3-dose regimen in the base study. A subset of participants (Cohort 1) received a fourth V503 mid-dose vaccination in the extension study.","id":"OG000","title":"Mid-dose V503"},{"description":"Gardasil (4-Valent HPV Vaccine) 0.5 mL injection in a 3-dose regimen in the base study. Participants (Cohort 2) were offered the V503 mid-dose 3-dose regimen in the extension study.","id":"OG001","title":"Gardasil"}],"paramType":"NUMBER","populationDescription":"The Per-protocol Immunogenicity population included all participants who were not protocol violators, received all 3 vaccinations of mid-dose V503 or Gardasil within acceptable ranges, were seronegative at Day 1 and PCR negative from Day 1 - Month 7 for the relevant HPV types, and had a Month 7 serum sample collected within an acceptable range","reportingStatus":"POSTED","timeFrame":"4 weeks postdose 3","title":"Base Study: Percentage of Participants Who Are Seropositive for HPV Types 6/11/16/18/31/33/45/52/58","type":"SECONDARY","unitOfMeasure":"Percentage of participants"}